Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in LSTA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 279K | $948K | +2.6% | 3.062% | 0.00% |
| 2 | Yakira Capital Management, Inc. | 139K | $471K | β | 1.522% | 0.13% |
| 3 | Deeter Investments LLP | 119K | $404K | β | 1.305% | 0.06% |
| 4 | CSS LLC/IL | 110K | $375K | +78.4% | 1.213% | 0.01% |
| 5 | DELTEC ASSET MANAGEMENT LLC | 83K | $283K | -7.6% | 0.914% | 0.04% |
| 6 | Rangeley Capital, LLC | 81K | $275K | +8.0% | 0.889% | 0.25% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 73K | $247K | +2.5% | 0.798% | 0.00% |
| 8 | BlackRock, Inc. | 55K | $187K | 0.0% | 0.602% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 49K | $166K | +40.2% | 0.538% | 0.00% |
| 10 | GTS SECURITIES LLC | 30K | $103K | -3.8% | 0.332% | 0.00% |
| 11 | STATE STREET CORP | 25K | $86K | 0.0% | 0.278% | 0.00% |
| 12 | JANE STREET GROUP, LLC | 19K | $64K | β | 0.206% | 0.00% |
| 13 | CITADEL ADVISORS LLC | 16K | $53K | -31.4% | 0.171% | 0.00% |
| 14 | NORTHERN TRUST CORP | 16K | $53K | +51.3% | 0.171% | 0.00% |
| 15 | JBF Capital, Inc. | 14K | $49K | +8.4% | 0.158% | 0.01% |
| 16 | Cerity Partners LLC | 12K | $41K | 0.0% | 0.134% | 0.00% |
| 17 | BANK OF AMERICA CORP /DE/ | 10K | $35K | 0.0% | 0.114% | 0.00% |
| 18 | HighTower Advisors, LLC | 10K | $34K | 0.0% | 0.110% | 0.00% |
| 19 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 5K | $17K | 0.0% | 0.055% | 0.00% |
| 20 | Founders Capital Management | 2K | $6K | 0.0% | 0.018% | 0.00% |
| 21 | Vanguard Global Advisers, LLC | 1K | $4K | 0.0% | 0.011% | 0.00% |
| 22 | Connective Capital Management, LLC | 1K | $3K | 0.0% | 0.011% | 0.00% |
| 23 | Tower Research Capital LLC (TRC) | 726 | $2K | -7.5% | 0.008% | 0.00% |
| 24 | OSAIC HOLDINGS, INC. | 200 | $680 | 0.0% | 0.002% | 0.00% |
| 25 | Caitong International Asset Management Co., Ltd | 90 | $306 | +309.1% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in LSTA β a direct measure of their conviction.
Filings activity in LSTA during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 33 | 2.9% | 13.27% | +1.79 pp | $4M | 22% |
| Q1 2026 | 34 | +31% | 11.48% | +3.38 pp | $5M | +271% |
| Q4 2025 | 26 | +13% | 8.10% | 0.50 pp | $1M | 31% |
| Q3 2025 | 23 | +0.0% | 8.60% | 0.47 pp | $2M | 13% |
| Q2 2025 | 23 | 8.0% | 9.07% | 0.02 pp | $2M | +23% |
| Q1 2025 | 25 | +8.7% | 9.09% | 0.25 pp | $2M | 21% |
| Q4 2024 | 23 | +0.0% | 9.34% | +0.12 pp | $2M | +1.5% |
| Q3 2024 | 23 | β | 9.22% | β | $2M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.
Quick answers to the most common questions about buying LSTA stock.
Based on Q2 2026 13F filings, institutional ownership of Lisata Therapeutics, Inc. stands at 13.3%, held across 33 reporting institutions.
VANGUARD CAPITAL MANAGEMENT LLC is the largest reported institutional holder of LSTA, with approximately 278,837 shares worth $0.00B as of Q2 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of LSTA, including JANE STREET GROUP, LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for LSTA is 57 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in LSTA during Q2 2026, while 5 fully exited. 3 added to existing positions and 24 trimmed.
LSTA institutional ownership rose by 1.79 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 88.5% of all reported 13F value in LSTA, and the top 25 account for 100.0%.
Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.